sg 110 and the heat shock protein seem promising both used for multiple cancers if they get approved that should be around 1-2billion in revenue long wise this stock is good but i would like to see management talk to the public more get some activity in this stock a day a drug gets approved red or green i expect vol exceeding 5 million not barely beating average. come on~~~!
heres what i think, JNJ would be the best bet for buying us out and i believe we are worth 800-1bil. Refering to a jnj buy out they are testing our heat shock protein with zytiga if they do well in combination I believe it would push things closer Dacogen,at13387 and sg 110 that is good money
I agree, Man uso turned down a $4 offer for Supergen. He said the offer was too low. I think his$5 options blinded his judgement. Instead we buy Astex. So far like Montigen his judgement is poor at best. These deals with large partners are good to limit risk but it also limits buyout potential.